The accumulated data have led to the development of several therapeutic strategies for AMD, such as verteporfin photodynamic therapy (PDT) [8], anti-vascular endothelial growth factor (VEGF) therapy [9], and combined therapy [10,11]. This evidence concerns the gene VEGFA and age-related macular degeneration.